Virometix
develops and commercializes vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and chronic human diseases... Read moreVirometix
develops and commercializes vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and chronic human diseases... Read more
News
Jul 13, 2021
FinanzNachrichten
Virometix: Virometix Announces Publication of Key Non-Clinical Proof-of-Concept Data in Two High Quality Peer-Reviewed Journals
Jan 07, 2021
FinanzNachrichten
Virometix: Virometix Broadens Senior Leadership Team with Three Key Appointments
Sep 17, 2020
Business Wire
Press Release: Virometix : Virometix Announces Completion of Initial Vaccination of the First Dose Cohort in Phase 1 Study with V-306
Jul 20, 2020
FinSMEs
Virometix: Virometix Closes CHF 7.5M Series B Funding Round
Jul 16, 2020
BioSpace
Virometix: Virometix Announces Successful Closing of Series B Investment Round raising CHF 7.5 million
Jul 09, 2020
firstwordpharma
Virometix: Anergis And Virometix Announce Research Collaboration To Use Synthetic Virus-Like Particles For Ultra-Fast Allergy Immunotherapy
Mar 16, 2020
startupticker
Virometix: Virometix to kick off in-human studies of its vaccine against virus infection
Mar 12, 2020
MarketScreener
Virometix: Virometix : Announces Initiation of Phase 1 Clinical Trial With Its V-306 Vaccine Candidate
Feb 04, 2019
startupticker
Virometix: Anna Sumeray takes over from Arin Ghasparian
Nov 14, 2018
NewMediaWire
Press Release: Virometix : GeoVax and Virometix to Collaborate on Immunotherapy Program for HPV Infections and Related Cancers
Virometix Competitors
1
2
3
4
5
6
7
8
9
10